Our transactions
Our Track Record
Over the last couple of years, Agile has successfully advised on over €1.1 billion worth of transactions and has closed 18 transactions in the last 18–24 months with global investors or strategic players across Europe, North America, Asia, and beyond.
ILife Consulting
EdgeCap-backed Comac Medical Group Expands with Acquisition of ILIFE Consulting, a French Early-phase Specialty CRO.
Clinomic
ICU Leader Clinomic Secures €23M Series B Investment to Drive AI & Data Innovation in Critical Care.
Cilcare
Cilcare completes a €40 million Series A to accelerate the development of innovative treatments for early hearing loss.
RIBOPRO
RIBOPRO Secures Series A funding to accelerate mRNA-Based technologies.
Discure Technologies
Discure Technologies developer of the Discure System, a bioelectronic implantable device for the treatment of degenerative disc disease (DDD), announces a $16 million series A.
Cilcare
Cilcare, a leading biotech company specializing in auditory sciences, announces a €400 million agreement with Shionogi.
BIOPHTA
BIOPHTA raises €6.5 million seed funding to transition its new standard of care for eye diseases to the clinical stage.
Acticor Biotech
Acticor Biotech completes a capital increase for a total gross amount of €8 million.
Undisclosed
New York based biotech company raises $110M series C to develop innovative treatments for schizophrenia.
Acticor Biotech
Acticor Biotech completes a capital increase for a total gross amount of approximately €2.6 million.
APICES
Spanish CRO APICES boosts its expansion and growth plans with the integration of the French CRO Kappa Santé.
Pherecydes
Merger of Erytech and Pherecydes and renamed Phaxiam Therapeutics.
Undisclosed
A company developing a microfluidic Cell and Gene Therapy manufacturing platform raises €16.5 million in seed funding.
Acticor Biotech
Acticor Biotech successfully completes a capital increase for a total gross amount of €12.2 million.
Backbone
Companion Spine acquires Backbone SAS, expanding its portfolio of medical implants dedicated to treating spine and back pain.
Lattice Medical
LATTICE MEDICAL, a French Medtech company providing patients and healthcare professionals with personalized tissue reconstruction solutions, closed a second round of financing of €8 million.
Incepto
Incepto, the AI platform for medical imaging, raised €27 million to support its European development.
Neurofenix
Neurofenix closes a $7 million Series A financing round led with AlbionVC as lead investor, with the participation of HTH, InHealth Ventures, and of existing investors.
Ludocare
Ludocare, specialist in digital therapies dedicated to pediatrics, announces a €4.2 million fund-raising round.
Spine Innovations
Spineway, a specialist in innovative implants for severe spinal pathologies, acquires 100% of the capital of Spine Innovations, a French company specializing in cervical and lumbar disc prostheses.
Domain Therapeutics
Domain Therapeutics raises $42 million Series A financing to accelerate clinical development of its best-in-class and first-in-class immuno-oncology programs.
FineHeart
FineHeart S.A, a preclinical medical device designed to address the unmet need of patients suffering from severe heart failure, raised a €15 million series B funding round.
Acticor Biotech
Success of Acticor Biotech’s Initial Public Offering on the Euronext Growth® market, with €15.5 million raised.
PKvitality
PKvitality, a French company specialized in bio wearables, has signed an agreement with Beurer GmBH, providing PKvitality with €2.25 million funding to further develop the K’Watch and reach FIH.
Acticor Biotech
Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, has raised €7 million in addition to its Series B, now completed at €22.3 million.
TransCure bioServices
TransCure bioServices, a French one-stop-shop preclinical services company dedicated to in-vivo full human immune system mouse models, completed a €2.5 million funding with Financière Arbevel.
Valcare Medical
Valcare Medical, a medtech company developing innovative minimally-invasive technologies for the treatment of mitral regurgitation, raises $26 millions series B led by a Chinese Medical Device company.
Acticor Biotech
Acticor biotech signed a €60 million regional development and commercialization agreement with China Medical System Holding Limited®.
EOS Imaging
EOS imaging has entered into a binding agreement with Fosun Pharmaceutical AG, an indirect subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., for c. €15.1 million.
EOS Imaging
EOS IMAGING, the pioneer of 2D/3D imaging and data solutions for orthopedics, completed an offering of bonds convertible for a nominal amount of c. €29.5 million.
STENTYS
STENTYS, a medtech company commercializing the Xposition S self-apposing coronary stent, acquired MINVASYS, independent specialist in innovative coronary devices marketed worldwide, for €11.8 million.
Cellnovo
Cellnovo concludes a loan agreement for up to €20 million from the European Investment Bank.
Cellnovo
Cellnovo Group, a medical technology company marketing the first mobile, connected, all-in-one diabetes management system, announced a capital raise of €17.5 million.
Cellnovo
Cellnovo raises circa €5.4 million in capital increase without preferential subscription rights.